Short term efficacy of a lifestyle intervention programme on cardiovascular health outcome in overweight Indigenous Australians with and without type 2 diabetes mellitus. The healthy lifestyle programme (HELP)

Diabetes Research and Clinical Practice

Volumn 75, Issue 1, 2007, Pages 65-71

  Chan, Lionel C K ^a   Ware, Robert ^a   Kesting, Janine ^a   Marczak, Maureen ^a   Good, David ^a   Shaw, Joanne T E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular risk; Indigenous Australians; Lifestyle intervention; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; AUSTRALIA; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; INDIGENOUS PEOPLE; INTERVENTION STUDY; LIFESTYLE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOMES RESEARCH; PATIENT MONITORING; PHYSICAL ACTIVITY; PROTEIN URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URBAN POPULATION; WAIST CIRCUMFERENCE;

COHORT STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; OVERWEIGHT; PATIENT EDUCATION; PHYSICAL FITNESS; POPULATION GROUPS; PROSPECTIVE STUDIES; QUEENSLAND; TREATMENT OUTCOME;

EID: 33845252478     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.04.012     Document Type: Article

References (30)

1. O'Dea K. Westernisation, insulin resistance and diabetes in Australian aborigines. Med. J. Aust. 155 (1991) 258-264
2. Thompson P.L., Bradshaw P.J., Veroni M., and Wilkes E.T. Cardiovascular risk among urban Aboriginal people. Med. J. Aust. 179 (2003) 143-146
3. Australian Bureau of Statistics: 4715.0 National Health Survey: Aboriginal and Torres Strait Islander Results. Canberra, ABS, 2002.
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes UKPDS 38. BMJ 317 (1998) 703-713
5. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33. Lancet 352 (1998) 837-853
6. Stamler J., Vaccaro O., Neaton J., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabet. Care 16 (1993) 434-444
7. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high risk individuals: a randomized placebo controlled trial. Lancet 360 (2002) 7-22
8. Pyorala K., Pederson T.R., Kjekhus J., Faergeman O., Olsson A.G., and Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabet. Care 20 (1997) 614-620
9. Danesh J., and Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J. Cardiovasc. Risk 5 (1998) 229-232
10. Valmadrid C.T., Klein R., Moss S.E., and Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 160 (2000) 1093-1100
11. Hubert H.B., Feinleib M., and McNamara D.M. Obesity is an independent risk factor for cardiovascular disease: a 26 year follow up of participants in the Framingham Heart study. Circulation 67 (1983) 968-977
12. Gaede P., Vedel P., Larsen N., Jensen G.V.H., Parving H.-H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
13. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
14. Simons L.A., Simons J., McCallum J., and Friedlander Y. Impact of smoking, diabetes and hypertension on survival time in the elderly: The Dubbo Study. Med. J. Aust. 182 (2005) 219-222
15. Currie C.J., Morgan C.L., Dixon S., McEwan P., Marchant N., Bearne A., et al. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabet. Res. Clin. Pract. 67 (2005) 144-151
16. Wang Z., and Hoy W.E. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?. Med. J. Aust. 182 (2005) 66-69
17. Rowley K., Daniel M., and Skinner K. Effectiveness of a community directed healthy lifestyle programme in a remote Australian Aboriginal community. Aust. N. Z. J. Pub. Health 24 (2000) 136-144
18. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes 33 (1984) 596-603
19. Alberti K.G.M.M., Aschner P., Assal J.-P., Bennett P.H., Groop L., Jervell J., et al. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications-Report of a WHO consultation (1999), World Health Organization, Geneva pp. 1-59
20. World Health Organization, Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, WHO, 1998.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Yokoyama H., Emoto M., Fujiwara S., Motoyama K., Morioka T., Komatsu M., et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabet. Care 26 (2003) 2426-2432
23. Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., and Matthews D.R. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom prospective diabetes study UKPDS 23. BMJ 316 (1998) 823-828
24. The Practical Implementation Taskforce for the Prevention of Cardiovascular Disease. Prevention of cardiovascular disease: an evidence-based clinical aid. Med. J. Aust. 18 (2004) F1-F14
25. Beilin J., Stanton K.G., McCann V.J., Knuiman M.W., and Divitini M.L. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust. N. Z. J. Med. 26 (1996) 519-525
26. Gall M.-A., Borch-Hohnsen K., Hougaard P., Nielsen F.S., and Parving H.-H. Albuminuria and poor glycemic control predict mortality in NIDDM (non-insulin-dependent diabetes mellitus). Diabetes 44 (1995) 1303-1309
27. Wiltshire S., Frayling T.M., Groves C.J., Levy J.C., Hitman G.A., Sampson M., et al. Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. Diabetes 53 (2004) 855-860
28. ALLHAT Group. Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
29. Welborn T.A., Dhaliwal S.S., and Bennett S.A. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med. J. Aust. 179 (2003) 580-585
30. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774